Stability Testing Of rBV A/B And rF1V Critical Material Lots

Closed Pre-Solicitation Posted

Not the latest version. See the latest solicitation from .

Solicitation number
W911QY-21-R-0021
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

This pre-solicitation notice seeks proposals for stability testing of recombinant Botulinum A/B and recombinant Plague F1V critical material lots and reagents. The U.S. Army Contracting Command - Aberdeen Proving Ground, Natick Division, on behalf of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense, intends to issue a full and open competition solicitation for a firm fixed price contract with a period of performance of 60 months and comprised of a 12-month base period and four 12-month option periods. Proposals will be evaluated using a tradeoff technique considering capability to successfully execute or manage the required stability testing in compliance with FDA and ICH regulations. The deadline for questions is April 16, 2021 and a solicitation is expected to be issued within 15 days of this notice.

There is no set-aside designation. The NAICS code is 541715 and work is expected to be performed at locations to be determined. Data generated will be considered DOD CUI and fall under ITAR restrictions. No award values were provided but stability testing will continue for several lots of drug product, drug substance, and other critical reagents associated with the rBV A/B and rF1V vaccines.

Notice text

The U.S. Army Contracting Command – Aberdeen Proving Ground, Natick Division, on behalf of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), Joint Project Manager for Chemical Biological Radiological and Nuclear – Medical (JPM-CBRN-Medical), Joint Project Lead – BIO1 intends to issue a full and open competition solicitation for Stability Testing of Drug Product, Drug Substance, Reference Materials, recombinant Botulinum A/B (rBV A/B)  vaccine materials, and recombinant Plague F1V (rF1V) vaccine materials. The anticipated period of performance is 60 months after date of contract award, comprised of one 12-month base period with four 12 month option periods.

The solicitation may result in a firm fixed price contract(s) for the conduct of 3, 6, and 12 month stability testing to continue stability testing of rBV A/B and rF1V critical material lots and reagents in anticipation of ongoing and future activities.  Testing of critical material includes the continued testing of several lots of cGMP drug product (DP), cGMP drug substance (DS), associated reference materials, and other critical reagents. Stability testing shall require compliance/conformance with regulations established by the U.S. Food and Drug Administration's (FDA) such as Good Manufacturing Practice regulations (cGMP) and International Conference on Harmonization (ICH) guidelines. Interested parties must be capable of successfully executing or managing the required Stability Testing.

Data generated under the contract will be considered Department of Defense Controlled Unclassified Information (CUI) and fall under ITAR 120.10 whose export is restricted by the Arms Export Control Act (Title 22, U.S.C. Sec 2778, et seq.) Violations of United States export laws are subject to severe criminal penalties.

The Government intends to use FAR Part 12 for this acquisition as commercial services may satisfy the agency’s requirement. It is anticipated a firm fixed price contract will be awarded to a single contractor. A combination of evaluation techniques may be utilized for this acquisition, a tradeoff evaluation technique is contemplated.

Any subsequent solicitation related to this pre-solicitation notice is expected to be issued within 15 days of the published date of this notice.

The North American Industry Classification System (NAICS) code for this procurement is

541715. In accordance with DFARS

252.204-7004, Alternate A, all interested offerors shall be registered in the

System for Award Management (SAM) database.

Proposal costs or any responses to this notice shall not be reimbursed. If a full solicitation is released, all interested parties will be able to view, download, and print a copy of the solicitation and any resulting amendments at beta.sam.gov, reference:W911QY-21-R-0021

No telephone calls will be accepted. No paper copies of the RFP will be provided and no mailing list will be maintained.

All inquiries related to this notification should reference in the Subject Line RFP number W911QY-21-R-0021.

Contracting Office Information:

ACC-APG - Natick, Natick Division

Building 1, Kansas Street, Natick, MA 01760-5011

Place of Performance: To be Determined (TBD)

ACC-APG - Natick (SPS) ATTN: AMSRD-ACC-N, Natick Contracting Division, Building 1, Kansas Street Natick MA

01760-5011

US

Point of Contact(s):

Scott Hoffman, Contract Specialist

Scott.i Hoffman2.civ@mail.mil

Notice history

Notice Type Posted
Stability Testing Of rBV A/B And rF1V Critical Material Lots Latest solicitation Solicitation
This notice Pre-Solicitation
Sources Sought Notice (SSN) Stability Testing Of rBV A/B And rF1V Critical Material Lots Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
Stability Testing for ManNAc Drug Product produced in Campaigns 5 and 6. Stability testing will occur under regulatory compliance Bethesda, Maryland 20892, United States · NAICS 541380 Office of Logisitics and Acquisition Operations No set-aside
Request for Information – Prophylactic Platform for Medical Countermeasures Frederick, Maryland 21702, United States · NAICS 541715 ACC Aberdeen Proving Ground No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors